Intellia Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NTLA and other ETFs, options, and stocks.

About NTLA

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. 

CEO
John M. Leonard
CEOJohn M. Leonard
Employees
526
Employees526
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2014
Founded2014
Employees
526
Employees526

NTLA Key Statistics

Market cap
1.12B
Market cap1.12B
Price-Earnings ratio
-2.02
Price-Earnings ratio-2.02
Dividend yield
—
Dividend yield—
Average volume
3.78M
Average volume3.78M
High today
$11.46
High today$11.46
Low today
$10.89
Low today$10.89
Open price
$11.27
Open price$11.27
Volume
2.05M
Volume2.05M
52 Week high
$34.87
52 Week high$34.87
52 Week low
$9.25
52 Week low$9.25

Analyst ratings

79%

of 28 ratings
Buy
78.6%
Hold
21.4%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.